Pressmeddelande

BioStock: Spago Nanomedical in hot area

Cision Publicerad: 13 Sep 2022 08:46

Radionuclide therapies for cancer is a hot area that has been noticed through clinical advances, approved drugs and completed licensing deals. First North-listed Spago Nanomedical is in the process of entering clinical phase with its drug candidate ¹⁷⁷Lu-SN201, which is expected to have wide use in this particular area.

Read the article about Spago Nanomedical at biostock.se:

https://www.biostock.se/en/2022/09/spago-nanomedical-in-hot-area/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Nyheter om Spago Nanomedical

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!